Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 18, Number 7—July 2012

Research

Validity of International Health Regulations in Reporting Emerging Infectious Diseases

Michael EdelsteinComments to Author , David L. Heymann, Johan Giesecke, and Julius Weinberg

Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (M. Edelstein, D.L. Heymann); Chatham House, London (D.L. Heymann); European Centre for Disease Control, Stockholm, Sweden (J. Giesecke); and Kingston University, London (J. Weinberg)

Main Article

Table 2

Characteristics of 175 EID events reported to WHO*

Characteristic No. (%)
Type of pathogen
Bacterium 89 (50.9)
Virus 39 (22.3)
Rickettsia 12 (6.9)
Protozoan 20 (11.4)
Helminth 2 (1.1)
Fungus 12 (6.9)
Prion 1 (0.6)
WHO region
AMRO 77 (44.0)
EURO 49 (28.0)
EMRO 7 (4.0)
SEARO 10 (5.7)
WPRO 24 (13.7)
AFRO 8 (4.6)
Type of event
New pathogen 70 (40.0)
Increased incidence 44 (25.1)
Antimicrobial drug resistance 54 (30.9)
New clinical manifestation 7 (4.0)

*EID, emerging infectious disease; WHO, World Health Organization; AMRO, Americas; EURO, Europe; EMRO, Eastern Mediterranean; SEARO, Southeast Asia; WPRO, Western Pacific; AFRO, Africa.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO